Cite
HARVARD Citation
Gaudinski, M. et al. (2018). Safety, tolerability, and immunogenicity of two Zika virus DNA vaccine candidates in healthy adults: randomised, open-label, phase 1 clinical trials. Lancet. 391 (10120), pp. 552-562. [Online].